The prolonged lockdown of health facilities providing non urgent gamete cryopreservation as currently recommended by many reproductive medicine entities and regulatory authorities due to the SARS CoV 2 pandemic will be detrimental for subgroups of male infertility patients. ...These groups include male infertility patients e.g., azoospermic men and cryptozoospermic undergoing medical or surgical treatment to improve sperm quantity and quality, as well as males of reproductive age affected by inflammatory and systemic auto immune diseases who are about to start treatment with gonadotoxic drugs or who are under remission. ...